SciGen Pte Ltd
About SciGen Pte Ltd
Categories
-
SG -
2020On CPHI since
Products from SciGen Pte Ltd (3)
-
Product Contact Us
Reach out to our representative for a deeper conversation today. -
Product GENSULIN / SciLin
Recombinant Human Insulin -
Product Scitropin A
Biosynthetic human growth hormone
SciGen Pte Ltd Resources (2)
-
News Yifan Pharma’s unit, eyeing US$5.5 billion post-chemotherapy treatment market dominated by Amgen, considers IPO in 2021
Evive’s F-627 candidate has shown promising results after several phase three clinical trials, CEO Liu Jubo says
Amgen’s second best-seller Neulasta, whose patent expired five years ago, generated US$3.2 billion of sales in 2019
-
Video Corporate Video
Find out more about our insulin manufacturing plant in Poland.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance